Hub : Traits :

Lupus

222 significantly associated models · 57 unique genes.

Significant Loci

# chr p0 p1 # assoc genes # joint genes best TWAS P best SNP P cond SNP P % var exp joint genes
1 2 190521054 192254289 4 2 3.1e-18 9.7e-66 1.4e-53 19 MFSD6 NAB1
2 3 57622089 59105913 2 1 1.8e-08 1.3e-07 6.3e-01 99 PXK
3 4 102093807 103243101 1 1 2.4e-07 4.5e-10 9.0e-05 60 BANK1
4 6 34065982 35552627 2 2 1.3e-09 3.3e-08 2.9e-02 84 TAF11 UHRF1BP1
5 7 127812871 129502461 6 10 1.5e-44 3.8e-45 NaN NaN ATP6V1F IRF5 RP11-286H14.6 TSPAN33
6 8 10265712 11891593 6 6 2.7e-16 5.2e-18 NaN NaN AF131215.2 AF131215.9 BLK FAM167A
7 11 198510 1423176 10 2 1.6e-12 3.5e-11 2.4e-02 88 HRAS TMEM80
8 11 34189564 35949179 2 2 2.4e-11 2.9e-11 9.8e-01 100 APIP CD44
9 12 128579481 130007356 1 1 2.1e-08 1.0e-07 4.8e-03 72 SLC15A4
10 16 30154740 31957368 7 7 1.4e-32 1.8e-46 NaN NaN BCL7C HSD3B7 ITGAD ITGAM MIR4519
11 17 37363793 38783469 4 1 8.1e-10 5.3e-07 9.1e-01 100 IKZF3
12 19 1473344 2923263 1 1 2.7e-07 3.8e-06 1.2e-01 89 DOT1L
13 19 9755448 11146499 2 2 3.0e-08 1.5e-12 9.6e-08 43 ICAM3 ICAM5
14 22 21075537 22685340 4 1 4.1e-15 8.3e-14 3.2e-01 98 CCDC116

Pleiotropic Associations

Trait chisq ratio # genes+ # genes++ % genes++ corr corr P genes
Schizophrenia (2018) 1.29 1 0 0.0 0.00 1.0e+00 DOT1L
Crohns Disease (2017) 1.76 2 1 2.2 0.00 1.0e+00 CCDC116 IKZF3
Irritable Bowel Disease (IBD) 2.20 2 2 4.4 0.00 1.0e+00 CCDC116 IKZF3
Ulcerative Colitis (UC) 3.45 3 1 2.2 0.96 1.7e-04 CCDC116 IKZF3 IRF5
Breast Cancer 1.02 1 0 0.0 0.00 1.0e+00 HRAS
Crohns Disease (2012) 1.69 1 1 2.2 0.00 1.0e+00 CCDC116
HDL Cholesterol 1.89 2 2 4.4 0.00 1.0e+00 CCDC116 IKZF3
Neuroticism (2016) 4.36 3 3 6.7 -1.00 6.6e-04 AF131215.2 AF131215.9 BLK
Primary Biliary Cirrhosis 11.74 8 2 4.4 0.99 6.6e-12 ATP6V1F ICAM3 ICAM5 IKZF3 IRF5 MFSD6 NAB1 TSPAN33
Rheumatoid Arthritis 6.85 7 1 2.2 0.99 2.8e-09 ATP6V1F BLK FAM167A ICAM3 ICAM5 IRF5 NAB1
Schizophrenia (2014) 1.28 1 0 0.0 0.00 1.0e+00 DOT1L
Triglycerides 2.19 1 0 0.0 0.00 1.0e+00 AF131215.9
Ulcerative Colitis 4.54 2 1 2.2 -0.01 9.9e-01 IKZF3 IRF5
Blood Eosinophil Count 1.99 8 4 8.9 -0.70 4.9e-03 BCL7C CCDC116 HRAS IKZF3 IRF5 MIR4519 NAB1 RP11-286H14.6
Blood Platelet Count 1.37 9 3 6.7 -0.60 1.8e-02 BANK1 HRAS ICAM3 ICAM5 IKZF3 IRF5 NAB1 TSPAN33 UHRF1BP1
Blood Red Count 1.11 7 4 8.9 -0.28 5.0e-01 DOT1L HSD3B7 IKZF3 ITGAM MIR4519 NAB1 PXK
Blood White Count 2.55 7 4 8.9 -0.66 1.1e-01 BCL7C CCDC116 HRAS ICAM3 ICAM5 IKZF3 MIR4519
Heel T-Score 1.89 8 4 8.9 -0.45 1.6e-01 BCL7C CCDC116 CD44 DOT1L ICAM3 IRF5 MIR4519 NAB1
BMI 1.38 7 2 4.4 0.32 4.8e-01 BCL7C ICAM3 ICAM5 MIR4519 PXK TAF11 UHRF1BP1
Height 0.77 9 5 11.1 -0.21 4.8e-01 BANK1 CCDC116 DOT1L HRAS ICAM3 IRF5 NAB1 TAF11 UHRF1BP1
Waist Hip Ratio (WHR) 1.11 3 2 4.4 0.00 1.0e+00 DOT1L HRAS UHRF1BP1
Systolic Blood Pressure 1.22 5 2 4.4 -0.46 3.6e-01 BANK1 CCDC116 DOT1L IRF5 NAB1
Allergy or Eczema 2.46 6 2 4.4 -0.10 8.5e-01 BLK CCDC116 FAM167A ICAM3 ICAM5 IKZF3
Cardiovascular Disease 1.13 2 0 0.0 0.00 1.0e+00 BANK1 ICAM5
Hypothyroidism (self reported) 4.38 9 2 4.4 0.86 1.9e-04 CCDC116 IKZF3 IRF5 MFSD6 NAB1 PXK SLC15A4 TMEM80 UHRF1BP1
Respiratory disease 3.16 2 1 2.2 0.00 1.0e+00 ICAM3 IKZF3
Lung FEV1/FVC ratio 0.94 5 1 2.2 0.18 7.7e-01 APIP HRAS ICAM3 IKZF3 ITGAD
Lung FVC 0.82 2 0 0.0 0.00 1.0e+00 DOT1L IKZF3
Hair Pigment 0.08 1 0 0.0 0.00 1.0e+00 CD44
Hand grip strength (left) 1.73 1 0 0.0 0.00 1.0e+00 BANK1
Sensitivity / hurt feelings 2.86 3 2 4.4 -0.99 7.2e-03 AF131215.2 AF131215.9 BLK
Relative age of first facial hair 1.01 1 0 0.0 0.00 1.0e+00 APIP
Systolic blood pressure, automated reading 2.67 5 3 6.7 0.75 5.2e-02 AF131215.2 AF131215.9 BLK DOT1L NAB1
Impedance of leg (right) 1.97 5 3 6.7 -0.96 5.8e-04 AF131215.2 AF131215.9 BCL7C BLK UHRF1BP1
Leg fat-free mass (left) 1.13 6 2 4.4 0.92 2.9e-03 AF131215.2 AF131215.9 BCL7C ITGAM MIR4519 UHRF1BP1
Trunk fat percentage 1.19 4 1 2.2 0.89 1.1e-01 BCL7C ITGAM MIR4519 UHRF1BP1
Hand grip strength (right) 1.77 2 0 0.0 0.00 1.0e+00 DOT1L IRF5
Current tobacco smoking 1.97 1 0 0.0 0.00 1.0e+00 AF131215.9
Fed-up feelings 2.41 2 2 4.4 0.00 1.0e+00 AF131215.2 AF131215.9
Taking other prescription medications 1.46 1 0 0.0 0.00 1.0e+00 IKZF3
Age when periods started (menarche) 1.55 2 0 0.0 0.00 1.0e+00 BANK1 IRF5
Heel bone mineral density (BMD) T-score, automated (left) 4.46 4 4 8.9 0.97 1.8e-03 AF131215.2 AF131215.9 BLK CD44
High blood pressure 2.64 6 2 4.4 0.73 6.5e-02 AF131215.2 AF131215.9 BCL7C BLK DOT1L ICAM5
Hayfever, allergic rhinitis or eczema 2.23 4 2 4.4 0.34 6.6e-01 CCDC116 ICAM3 ICAM5 IKZF3
Medication: Levothyroxine sodium 4.20 6 1 2.2 0.58 1.7e-01 AF131215.2 AF131215.9 IRF5 MFSD6 NAB1 UHRF1BP1
Sitting height 0.83 4 1 2.2 0.32 6.8e-01 CCDC116 DOT1L HRAS NAB1
Body mass index (BMI) 2.61 7 5 11.1 0.92 1.3e-03 AF131215.2 AF131215.9 BCL7C BLK ITGAM MIR4519 UHRF1BP1
Impedance of leg (left) 2.05 5 3 6.7 -0.96 5.6e-04 AF131215.2 AF131215.9 BLK CCDC116 UHRF1BP1
Leg predicted mass (left) 1.12 6 2 4.4 0.93 2.8e-03 AF131215.2 AF131215.9 BCL7C ITGAM MIR4519 UHRF1BP1
Trunk fat mass 1.27 5 1 2.2 0.91 3.1e-02 AF131215.9 BCL7C ITGAM MIR4519 UHRF1BP1
Waist circumference 1.09 4 1 2.2 0.94 6.1e-02 BCL7C ITGAM MIR4519 UHRF1BP1
Nervous feelings 3.93 3 3 6.7 -1.00 1.9e-03 AF131215.2 AF131215.9 BLK
Forced vital capacity (FVC) 1.37 3 0 0.0 0.00 1.0e+00 NAB1 TAF11 UHRF1BP1
Heel bone mineral density (BMD) T-score, automated (right) 4.74 4 4 8.9 0.97 1.0e-03 AF131215.2 AF131215.9 BLK CD44
Mouth/teeth dental problems 2.45 1 0 0.0 0.10 9.0e-01 IRF5
Allergy 2.49 4 1 2.2 -0.05 9.5e-01 CCDC116 ICAM3 ICAM5 IKZF3
Hayfever/allergic rhinitis (self-reported) 2.47 2 1 2.2 0.00 1.0e+00 BCL7C IKZF3
Neuroticism score 4.24 3 3 6.7 -0.99 1.5e-03 AF131215.2 AF131215.9 BLK
Weight 1.39 6 4 8.9 0.94 1.4e-03 AF131215.2 AF131215.9 BCL7C ITGAM MIR4519 UHRF1BP1
Impedance of arm (right) 2.11 5 2 4.4 -0.70 1.2e-01 AF131215.2 AF131215.9 BCL7C BLK ICAM5
Arm fat percentage (right) 1.75 7 2 4.4 0.91 1.9e-03 AF131215.2 AF131215.9 BCL7C BLK ITGAM MIR4519 UHRF1BP1
Trunk fat-free mass 0.78 3 0 0.0 0.00 1.0e+00 AF131215.2 AF131215.9 DOT1L
Hip circumference 1.88 6 5 11.1 0.94 1.6e-03 AF131215.2 AF131215.9 BCL7C ITGAM MIR4519 UHRF1BP1
Worrier / anxious feelings 4.42 3 3 6.7 -1.00 3.6e-03 AF131215.2 AF131215.9 BLK
Forced expiratory volume in 1-second (FEV1) 1.53 2 1 2.2 0.00 1.0e+00 AF131215.9 TAF11
Serious illness, injury or assault of a close relative in last 2 years 1.34 1 0 0.0 0.00 1.0e+00 AF131215.9
Mouth/teeth dental problems: Dentures 1.60 1 0 0.0 0.00 1.0e+00 AF131215.9
Asthma 3.25 2 1 2.2 0.00 1.0e+00 ICAM3 IKZF3
Forced expiratory volume in 1-second (FEV1), Best measure 1.31 2 1 2.2 0.00 1.0e+00 TAF11 UHRF1BP1
Impedance of arm (left) 1.87 4 2 4.4 -0.62 2.6e-01 AF131215.2 AF131215.9 BCL7C ICAM5
Arm fat mass (right) 1.84 6 4 8.9 0.91 4.2e-03 AF131215.2 AF131215.9 BCL7C ITGAM MIR4519 UHRF1BP1
Trunk predicted mass 0.78 3 0 0.0 0.00 1.0e+00 AF131215.2 AF131215.9 DOT1L
Standing height 0.98 7 1 2.2 -0.44 1.6e-01 AF131215.9 CCDC116 DOT1L IRF5 NAB1 TAF11 UHRF1BP1
Length of working week for main job 2.16 1 0 0.0 0.00 1.0e+00 SLC15A4
Tense / 'highly strung' 2.53 3 2 4.4 -0.99 1.4e-02 AF131215.2 AF131215.9 BLK
Peak expiratory flow (PEF) 1.85 4 0 0.0 -1.00 4.2e-04 AF131215.2 AF131215.9 BLK TAF11
Gout (self-reported) 2.34 1 0 0.0 0.00 1.0e+00 IRF5
Hypothyroidism/myxoedema (self-reported) 4.98 9 2 4.4 0.45 1.4e-01 AF131215.2 AF131215.9 BLK CCDC116 IRF5 MFSD6 NAB1 PXK UHRF1BP1
Medication: Ventolin 100micrograms inhaler 1.90 1 1 2.2 0.00 1.0e+00 IKZF3
Forced vital capacity (FVC), Best measure 1.01 2 0 0.0 0.00 1.0e+00 TAF11 UHRF1BP1
Body fat percentage 1.38 4 1 2.2 0.89 1.1e-01 BCL7C ITGAM MIR4519 UHRF1BP1
Leg fat percentage (right) 1.60 6 1 2.2 0.91 1.2e-02 AF131215.2 AF131215.9 BCL7C ITGAM MIR4519 UHRF1BP1
Arm fat-free mass (right) 1.13 6 2 4.4 0.94 6.0e-03 AF131215.2 AF131215.9 BCL7C DOT1L ITGAM MIR4519
Comparative body size at age 10 2.34 3 2 4.4 0.84 1.6e-01 AF131215.2 AF131215.9 DOT1L
Worry too long after embarrassment 2.70 3 2 4.4 -1.00 3.8e-03 AF131215.2 AF131215.9 BLK
Seen a psychiatrist for nerves, anxiety, tension or depression 1.10 1 0 0.0 0.00 1.0e+00 NAB1
Wheeze or whistling in the chest in last year 1.67 1 1 2.2 0.00 1.0e+00 IKZF3
Qualifications: College or University degree 0.73 1 0 0.0 0.00 1.0e+00 IKZF3
Medication: Blood pressure 1.46 1 0 0.0 0.00 1.0e+00 AF131215.9
Whole body fat mass 1.50 6 2 4.4 0.92 3.5e-03 AF131215.2 AF131215.9 BCL7C ITGAM MIR4519 UHRF1BP1
Leg fat mass (right) 1.89 7 4 8.9 0.75 3.3e-02 AF131215.2 AF131215.9 BCL7C ICAM5 ITGAM MIR4519 UHRF1BP1
Arm predicted mass (right) 1.19 5 2 4.4 0.94 6.0e-03 AF131215.2 AF131215.9 BCL7C ITGAM MIR4519
Pulse rate, automated reading 0.91 2 0 0.0 0.00 1.0e+00 MFSD6 NAB1
Comparative height size at age 10 0.83 3 1 2.2 0.00 1.0e+00 BANK1 CCDC116 DOT1L
Suffer from 'nerves' 2.43 3 2 4.4 -1.00 1.4e-03 AF131215.2 AF131215.9 BLK
Overall health rating 1.50 1 0 0.0 0.00 1.0e+00 AF131215.2
Age at last live birth 1.63 1 0 0.0 0.00 1.0e+00 AF131215.9
Hypertension (Self-reported) 2.55 5 2 4.4 0.65 1.6e-01 AF131215.2 AF131215.9 BLK DOT1L ICAM5
Whole body fat-free mass 0.89 4 2 4.4 0.99 7.5e-03 AF131215.2 AF131215.9 BCL7C DOT1L
Leg fat-free mass (right) 1.04 4 2 4.4 0.97 5.6e-03 AF131215.2 AF131215.9 BCL7C UHRF1BP1
Arm fat percentage (left) 1.83 7 2 4.4 0.91 1.7e-03 AF131215.2 AF131215.9 BCL7C BLK ITGAM MIR4519 UHRF1BP1
Mood swings 2.32 3 2 4.4 -0.99 9.8e-03 AF131215.2 AF131215.9 BLK
Long-standing illness, disability or infirmity 1.20 1 0 0.0 0.00 1.0e+00 CCDC116
Mouth/teeth dental problems: Mouth ulcers 4.15 1 1 2.2 0.96 7.4e-04 IRF5
Asthma (self-reported) 3.25 1 1 2.2 0.00 1.0e+00 IKZF3
Smoking status: Current 1.92 2 0 0.0 0.00 1.0e+00 AF131215.2 AF131215.9
Forced expiratory volume in 1-second (FEV1), predicted percentage 2.08 3 0 0.0 0.00 1.0e+00 AF131215.9 BCL7C IKZF3
Whole body water mass 0.91 4 2 4.4 0.99 8.8e-03 AF131215.2 AF131215.9 BCL7C DOT1L
Leg predicted mass (right) 1.04 4 2 4.4 0.97 5.2e-03 AF131215.2 AF131215.9 BCL7C UHRF1BP1
Arm fat mass (left) 1.87 7 4 8.9 0.93 8.4e-04 AF131215.2 AF131215.9 BCL7C BLK ITGAM MIR4519 UHRF1BP1
Number of self-reported non-cancer illnesses 1.37 2 0 0.0 0.00 1.0e+00 IKZF3 RP11-286H14.6
Miserableness 2.39 2 2 4.4 0.00 1.0e+00 AF131215.2 AF131215.9
Guilty feelings 1.86 2 0 0.0 0.00 1.0e+00 AF131215.2 AF131215.9
Medication: Blood pressure 2.49 2 0 0.0 0.00 1.0e+00 AF131215.2 AF131215.9
High cholesterol (Self-reported) 0.95 1 0 0.0 0.00 1.0e+00 ICAM3
Medication: Bendroflumethiazide 2.50 3 0 0.0 1.00 8.9e-05 AF131215.2 AF131215.9 BCL7C
Basal metabolic rate 1.03 7 2 4.4 0.94 1.9e-03 AF131215.2 AF131215.9 BCL7C DOT1L ITGAM MIR4519 UHRF1BP1
Leg fat percentage (left) 1.67 6 2 4.4 0.91 4.4e-03 AF131215.2 AF131215.9 BCL7C ITGAM MIR4519 UHRF1BP1
Arm fat-free mass (left) 1.13 6 2 4.4 0.93 6.3e-03 AF131215.2 AF131215.9 BCL7C DOT1L ITGAM MIR4519
Average weekly beer plus cider intake 2.10 3 0 0.0 -1.00 2.9e-03 AF131215.2 AF131215.9 BLK
Irritability 4.23 3 3 6.7 -0.98 2.5e-03 AF131215.2 AF131215.9 BLK
Risk taking 1.49 2 0 0.0 0.00 1.0e+00 AF131215.2 AF131215.9
Fractured/broken bones in last 5 years 1.83 2 0 0.0 0.00 1.0e+00 ITGAM MIR4519
Diastolic blood pressure, automated reading 2.89 5 3 6.7 0.95 9.5e-04 AF131215.2 AF131215.9 BANK1 BLK FAM167A
Myopia 1.53 1 0 0.0 0.00 1.0e+00 IKZF3
Vascular/heart problems diagnosed by doctor 2.28 4 1 2.2 -1.00 7.6e-05 AF131215.2 AF131215.9 BCL7C BLK
Cholesterol lowering medication 1.39 2 0 0.0 0.00 1.0e+00 BCL7C MIR4519
Impedance of whole body 2.06 4 3 6.7 -0.99 1.0e-03 AF131215.2 AF131215.9 BCL7C BLK
Leg fat mass (left) 1.85 6 4 8.9 0.92 3.4e-03 AF131215.2 AF131215.9 BCL7C ITGAM MIR4519 UHRF1BP1
Arm predicted mass (left) 1.19 5 2 4.4 0.93 2.3e-02 AF131215.2 AF131215.9 BCL7C ITGAM MIR4519

Associations by panel

study tissue # hits % hits/tests avg chisq
GTEx Adipose Subcutaneous 4 0.115 1.5
GTEx Adipose Visceral Omentum 6 0.296 1.6
GTEx Adrenal Gland 3 0.208 1.6
GTEx Artery Aorta 7 0.236 1.5
GTEx Artery Coronary 2 0.170 1.8
GTEx Artery Tibial 4 0.107 1.5
GTEx Brain Caudate basal ganglia 1 0.110 1.5
GTEx Brain Cerebellar Hemisphere 0 0.000 1.5
GTEx Brain Cerebellum 4 0.203 1.5
GTEx Brain Cortex 1 0.097 1.6
GTEx Brain Frontal Cortex BA9 1 0.109 1.6
GTEx Brain Hippocampus 0 0.000 1.7
GTEx Brain Hypothalamus 0 0.000 1.5
GTEx Brain Nucleus accumbens basal ganglia 0 0.000 1.5
GTEx Brain Putamen basal ganglia 1 0.162 1.8
GTEx Breast Mammary Tissue 2 0.102 1.5
GTEx Breast Mammary Tissue (Male) 1 0.084 1.6
GTEx Breast Mammary Tissue (Female) 2 0.123 1.4
GTEx Cells EBV-transformed lymphocytes 1 0.071 1.6
GTEx Cells Transformed fibroblasts 2 0.048 1.5
GTEx Colon Sigmoid 2 0.138 1.6
GTEx Colon Transverse 2 0.098 1.6
GTEx Esophagus Gastroesophageal Junction 2 0.139 1.5
GTEx Esophagus Mucosa 5 0.151 1.5
GTEx Esophagus Muscularis 6 0.187 1.6
GTEx Heart Atrial Appendage 3 0.191 1.7
GTEx Heart Left Ventricle 1 0.066 1.6
GTEx Liver 1 0.141 1.6
GTEx Lung 3 0.105 1.5
GTEx Muscle Skeletal 3 0.104 1.5
GTEx Nerve Tibial 5 0.116 1.5
GTEx Ovary 3 0.332 1.6
GTEx Pancreas 4 0.246 1.6
GTEx Pituitary 1 0.090 1.6
GTEx Prostate 1 0.121 1.5
GTEx Skin Not Sun Exposed Suprapubic 5 0.204 1.5
GTEx Skin Sun Exposed Lower leg 4 0.111 1.6
GTEx Small Intestine Terminal Ileum 2 0.440 1.7
GTEx Spleen 2 0.143 1.7
GTEx Stomach 0 0.000 1.5
GTEx Testis 4 0.127 1.5
GTEx Thyroid 6 0.151 1.5
GTEx Uterus 0 0.000 1.6
GTEx Vagina 0 0.000 1.6
GTEx Whole Blood 5 0.252 1.7
METSIM Adipose 9 0.196 1.5
NTR Blood 3 0.125 1.5
ROSMAP Brain Pre-frontal Cortex 6 0.137 1.5
YFS Blood 4 0.087 1.5
CommonMind Brain Pre-frontal Cortex 5 0.093 1.4
The Cancer Genome Atlas Bladder Urothelial Carcinoma 4 0.242 1.6
The Cancer Genome Atlas Breast Invasive Carcinoma 9 0.205 1.5
The Cancer Genome Atlas Cervical Squamous Cell Carcinoma 2 0.183 1.6
The Cancer Genome Atlas Colon Adenocarcinoma 3 0.146 1.5
The Cancer Genome Atlas Esophageal Carcinoma 0 0.000 1.4
The Cancer Genome Atlas Glioblastoma Multiforme 3 0.295 1.6
The Cancer Genome Atlas Head and Neck Squamous Cell Carcinoma 3 0.110 1.5
The Cancer Genome Atlas Kidney Renal Clear Cell Carcinoma 6 0.147 1.5
The Cancer Genome Atlas Kidney Renal Papillary Cell Carcinoma 5 0.245 1.7
The Cancer Genome Atlas Brain Lower Grade Glioma 6 0.140 1.5
The Cancer Genome Atlas Liver Hepatocellular Carcinoma 2 0.182 1.6
The Cancer Genome Atlas Lung Adenocarcinoma 1 0.034 1.5
The Cancer Genome Atlas Lung Squamous Cell Carcinoma 3 0.120 1.5
The Cancer Genome Atlas Ovarian Serous Cystadenocarcinoma 3 0.189 1.5
The Cancer Genome Atlas Pancreatic Adenocarcinoma 4 0.242 1.6
The Cancer Genome Atlas Pheochromocytoma and Paraganglioma 1 0.076 1.5
The Cancer Genome Atlas Prostate Adenocarcinoma 7 0.152 1.5
The Cancer Genome Atlas Rectum Adenocarcinoma 3 0.435 1.8
The Cancer Genome Atlas Soft Tissue Sarcoma 1 0.094 1.6
The Cancer Genome Atlas Skin Cutaneous Melanoma 1 0.188 1.6
The Cancer Genome Atlas Stomach Adenocarcinoma 4 0.238 1.5
The Cancer Genome Atlas Testicular Germ Cell Tumors 1 0.079 1.6
The Cancer Genome Atlas Thyroid Carcinoma 9 0.175 1.5
The Cancer Genome Atlas Uterine Corpus Endometrial Carcinoma 2 0.396 1.6